Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Want to see HK:1858 full AI Analyst Report?
1858 Stock Chart & Stats
HK$15.39
-HK$0.21(-2.63%)
At close: 4:00 PM EST
HK$15.39
-HK$0.21(-2.63%)
Day’s Range― - ―
52-Week RangeHK$8.99 - HK$20.82
Previous CloseN/A
Volume218.00K
Average Volume (3M)1.20M
Market Cap
HK$6.94B
Enterprise ValueHK$5.52B
Total Cash (Recent Filing)HK$2.10B
Total Debt (Recent Filing)HK$2.23M
Price to Earnings (P/E)18.0
Beta1.22
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.88%
Share Statistics
EPS (TTM)0.70
Shares Outstanding95,140,500
10 Day Avg. Volume978,626
30 Day Avg. Volume1,198,522
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.71
Price to Sales (P/S)5.06
P/FCF Ratio14.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.85
Revenue Forecast (FY)HK$1.35B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage provides durable financial flexibility: management can fund capex, R&D, dividends or acquisitions without relying on market financing. Low debt reduces solvency risk in downturns and supports consistent capital allocation over multiple quarters.
Resilient MarginsSustained gross and net margin strength signals pricing power or cost control that supports long-term cash generation. Robust margins help absorb revenue swings, maintain profitability during slower periods, and enable reinvestment in product and market development.
Positive Trailing Cash GenerationRecent strong operating and free cash flow that covers most net income improves the company’s ability to self-fund operations and return capital. Reliable cash conversion supports sustainable dividends, working-capital needs, and strategic investments over intermediate horizons.
Bears Say
Revenue VolatilitySharp revenue declines and recent TTM weakness reduce visibility into demand and undermine growth planning. Persistent top-line volatility can erode operating leverage, complicate capacity and R&D decisions, and limit the predictability of future earnings and cash flows.
Choppy Historical Cash FlowIntermittent negative operating or free cash flow indicates exposure to working-capital swings or lumpy investments. That volatility increases reliance on cash buffers, can force timing delays in capital projects, and raises risk during multi-quarter stress despite recent TTM improvement.
Variable Shareholder ReturnsMeaningful ROE variation points to inconsistent profitability or capital efficiency, making longer-term return forecasts uncertain. Fluctuating returns can reflect cyclic end-market demand or execution risk, complicating assessment of sustainable shareholder value creation.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H News
1858 FAQ
What was Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H lowest stock price was HK$8.99 and its highest was HK$20.82 in the past 12 months.
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap is HK$6.94B.
When is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Aug 28, 2026 which is in 110 days.
How were Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H released its earnings results on Apr 29, 2026. The company reported HK$0.184 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.184.
Is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pay dividends?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays a Semiannually dividend of HK$0.23 which represents an annual dividend yield of 1.88%. See more information on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H dividends here
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H have?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding.
What happened to Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.184 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.41%.
Which hedge fund is a major shareholder of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1858
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
99.89%
12-Months-Change
Fundamentals
Return on Equity
9.25%
Trailing 12-Months
Asset Growth
10.60%
Trailing 12-Months
Company Description
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Earnings & Revenues
Technical Analysis
Peijia Medical Ltd.
―
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
―
LifeTech Scientific Corporation
―
China Isotope & Radiation Corp.
―
AK Medical Holdings Ltd.
―
Options Prices
Currently, No data available
---